KLIFS: A structural kinase-ligand interaction database

Nucleic Acids Research

Volumn 44, Issue D1, 2016, Pages D365-D371

  Kooistra, Albert J ^a   Kanev, Georgi K ^a   Van Linden, Oscar P J ^a   Leurs, Rob ^a   De Esch, Iwan J P ^a   De Graaf, Chris ^a  

^a AMSTERDAM INSTITUTE FOR MOLECULES   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE; AGAMMAGLOBULINAEMIA TYROSINE KINASE; LIGAND; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE;

ARTICLE; BINDING AFFINITY; ENZYME BINDING; ENZYME CONFORMATION; ENZYME STRUCTURE; LIGAND BINDING; MOLECULAR INTERACTION; ONLINE SYSTEM; PRIORITY JOURNAL; PROTEIN DATA BANK; PROTEIN DATABASE; SEQUENCE ALIGNMENT; STRUCTURE ANALYSIS; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; ENZYME ACTIVE SITE; HUMAN; INTERNET; METABOLISM; MOLECULAR GENETICS; MOUSE;

ANIMALS; CATALYTIC DOMAIN; DATABASES, PROTEIN; HUMANS; INTERNET; LIGANDS; MICE; MOLECULAR SEQUENCE ANNOTATION; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; PROTEIN-TYROSINE KINASES;

EID: 84976892909     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkv1082     Document Type: Article

References (32)

1. Manning, G., Whyte, D. B., Martinez, R., Hunter, T. and Sudarsanam, S. (2002) The protein kinase complement of the human genome. Science, 298, 1912-1934.
2. Cohen, P. (2002) Protein kinases-the major drug targets of the twenty-first century? Nat. Rev. Drug Discov., 1, 309-315.
3. Merritt, C., Silva, L. E., Tanner, A. L., Stuart, K. and Pollastri, M. P. (2014) Kinases as Druggable Targets in Trypanosomatid Protozoan Parasites. Chem. Rev., 114, 11280-11304.
4. Apsel, B., Blair, J. A., Gonzalez, B., Nazif, T. M., Feldman, M. E., Aizenstein, B., Hoffman, R., Williams, R. L., Shokat, K. M. and Knight, Z. A. (2008) Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases. Nat. Chem. Biol., 4, 691-699.
5. van Linden, O. P., Kooistra, A. J., Leurs, R., de Esch, I. J. and de Graaf, C. (2014) KLIFS: a knowledge-based structural database to navigate kinase-ligand interaction space. J. Med. Chem., 57, 249-277.
6. Rose, P. W., Prlic, A., Bi, C., Bluhm, W. F., Christie, C. H., Dutta, S., Green, R. K., Goodsell, D. S., Westbrook, J. D., Woo, J. et al. (2015) The RCSB Protein Data Bank: views of structural biology for basic and applied research and education. Nucleic Acids Res., 43, D345-D356.
7. Gutmanas, A., Alhroub, Y., Battle, G. M., Berrisford, J. M., Bochet, E., Conroy, M. J., Dana, J. M., Fernandez Montecelo, M. A., van Ginkel, G., Gore, S. P. et al. (2014) PDBe: Protein Data Bank in Europe. Nucleic Acids Res., 42, D285-D291.
8. Lamba, V. and Ghosh, I. (2012) New directions in targeting protein kinases: focusing upon true allosteric and bivalent inhibitors. Curr. Pharm. Des., 18, 2936-2945.
9. Marcou, G. and Rognan, D. (2007) Optimizing fragment and scaffold docking by use of molecular interaction fingerprints. J. Chem. Inf. Model., 47, 195-207.
10. Altschul, S. F., Madden, T. L., Schaffer, A. A., Zhang, J., Zhang, Z., Miller, W. and Lipman, D. J. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res., 25, 3389-3402.
11. Westbrook, J. D., Shao, C., Feng, Z., Zhuravleva, M., Velankar, S. and Young, J. (2015) The chemical component dictionary: complete descriptions of constituent molecules in experimentally determined 3D macromolecules in the Protein Data Bank. Bioinformatics, 31, 1274-1278.
12. Bietz, S., Urbaczek, S., Schulz, B. and Rarey, M. (2014) Protoss: a holistic approach to predict tautomers and protonation states in protein-ligand complexes. J. Cheminform., 6, 12.
13. Liao, J. J. L. and Andrews, R. C. (2007) Targeting protein multiple conformations: a structure-based strategy for kinase drug design. Curr. Top. Med. Chem., 7, 1394-1407.
14. Zhao, Z., Wu, H., Wang, L., Liu, Y., Knapp, S., Liu, Q. and Gray, N. S. (2014) Exploration of type II binding mode: A privileged approach for kinase inhibitor focused drug discovery? ACS Chem. Biol., 9, 1230-1241.
15. Quinlan, J. R. (1986) Induction of decision trees. Mach. Learn., 1, 81-106.
16. The UniProt Consortium. (2014) Activities at the Universal Protein Resource (UniProt). Nucleic Acids Res., 42, D191-D198.
17. Li, H., Leung, K. S., Nakane, T. and Wong, M. H. (2014) iview: an interactiveWebGL visualizer for protein-ligand complex. BMC Bioinformatics, 15, 56.
18. Chartier, M., Chenard, T., Barker, J. and Najmanovich, R. (2013) Kinome Render: a stand-alone and web-accessible tool to annotate the human protein kinome tree. PeerJ, 1, e126.
19. Kochev, N. T., Paskaleva, V. H. and Jeliazkova, N. (2013) Ambit - Tautomer: An Open Source Tool for Tautomer Generation. Mol. Inf., 32, 481-504.
20. Rogers, D. and Hahn, M. (2010) Extended-connectivity fingerprints. J. Chem. Inf. Model., 50, 742-754.
21. van Deursen, R., Blum, L. C. and Reymond, J. L. (2011) Visualisation of the chemical space of fragments, lead-like and drug-like molecules in PubChem. J. Comput. Aided Mol. Des., 25, 649-662.
22. de Graaf, C., Vischer, H. F., de Kloe, G. E., Kooistra, A. J., Nijmeijer, S., Kuijer, M., Verheij, M. H., England, P. J., van Muijlwijk-Koezen, J. E., Leurs, R. et al. (2013) Small and colorful stones make beautiful mosaics: fragment-based chemogenomics. Drug Discov. Today, 18, 323-330.
23. Gray, K. A., Yates, B., Seal, R. L., Wright, M. W. and Bruford, E. A. (2015) Genenames.org: the HGNC resources in 2015. Nucleic Acids Res., 43, D1079-D1085.
24. Davies, M., Nowotka, M., Papadatos, G., Dedman, N., Gaulton, A., Atkinson, F., Bellis, L. and Overington, J. P. (2015) ChEMBL web services: streamlining access to drug discovery data and utilities. Nucleic Acids Res., 43, W612-W620.
25. Desaphy, J., Bret, G., Rognan, D. and Kellenberger, E. (2015) sc-PDB: a 3D-database of ligandable binding sites-10 years on. Nucleic Acids Res., 43, D399-D404.
26. Chiu, Y. Y., Lin, C. T., Huang, J. W., Hsu, K. C., Tseng, J. H., You, S. R. and Yang, J. M. (2013) KIDFamMap: a database of kinase-inhibitor-disease family maps for kinase inhibitor selectivity and binding mechanisms. Nucleic Acids Res., 41, D430-D440.
27. Shi, Q., Tebben, A., Dyckman, A. J., Li, H., Liu, C., Lin, J., Spergel, S., Burke, J. R., McIntyre, K. W., Olini, G. C. et al. (2014) Purine derivatives as potent Bruton's tyrosine kinase (BTK) inhibitors for autoimmune diseases. Bioorg. Med. Chem. Lett., 24, 2206-2211.
28. Levinson, N. M. and Boxer, S. G. (2014) A conserved water-mediated hydrogen bond network defines bosutinib's kinase selectivity. Nat. Chem. Biol., 10, 127-132.
29. Furtmann, N., Hu, Y. and Bajorath, J. (2015) Comprehensive analysis of three-dimensional activity cliffs formed by kinase inhibitors with different binding modes and cliff mapping of structural analogues. J. Med. Chem., 58, 252-264.
30. Hu, Y., Furtmann, N. and Bajorath, J. (2015) Current compound coverage of the kinome. J. Med. Chem., 58, 30-40.
31. Mendez-Lucio, O., Kooistra, A. J., de Graaf, C., Bender, A. and Medina-Franco, J. L. (2015) Analyzing multitarget activity landscapes using protein-ligand interaction fingerprints: interaction cliffs. J. Chem. Inf. Model., 55, 251-262.
32. Shrake, A. and Rupley, J. A. (1973) Environment and exposure to solvent of protein atoms. Lysozyme and insulin. J. Mol. Biol., 79, 351-371.